Welcome: Guest | Site Use Options | Register | Login |

Kadmus Pharmaceuticals Inc

Kadmus Pharmaceuticals Inc

Profile last edited on: 8/22/2007
101 Theory Suite 100
Irvine, CA 92612
  (949) 725-3700
Business Identifier: NO Business Identifier is currently available for this company.
Public Profile:
Kadmus Pharmaceuticals Inc commercially exploits endocannabinoid pathways to develop innovative therapeutics. Endocannabinoids are naturally occurring signaling molecules whose functions include regulating pain and body weight. Through licensing activity, development partnerships and internal discovery programs, Kadmus Pharmaceuticals is building a portfolio of compounds with activity against a range of disorders of the central nervous system and metabolic disorders, including neuropathic pain and obesity

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Oleylethanolamide derivatives as anti-obesity agents
Identifying Ligands For A Novel Gabaa Receptor Subtype

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920